A detailed history of Israel Englander (Millennium Management LLC) transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 45,363 shares of XTNT stock, worth $18,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,363
Previous 62,682 27.63%
Holding current value
$18,145
Previous $39,000 23.08%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.55 - $0.8 $9,525 - $13,855
-17,319 Reduced 27.63%
45,363 $30,000
Q2 2024

Aug 14, 2024

SELL
$0.63 - $1.03 $110,831 - $181,200
-175,923 Reduced 73.73%
62,682 $39,000
Q1 2024

May 15, 2024

BUY
$0.92 - $1.28 $72,914 - $101,446
79,255 Added 49.74%
238,605 $279,000
Q4 2023

Feb 14, 2024

BUY
$1.04 - $1.39 $165,724 - $221,496
159,350 New
159,350 $180,000
Q4 2022

Feb 14, 2023

BUY
$0.5 - $0.8 $12,897 - $20,636
25,795 New
25,795 $17,000

Others Institutions Holding XTNT

About Xtant Medical Holdings, Inc.


  • Ticker XTNT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 108,226,000
  • Market Cap $43.3M
  • Description
  • Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...
More about XTNT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.